Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Hay

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
British Journal of Clinical Pharmacology|January 1, 1988
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarinI A Choonara, R G Malia, B P Haynes, et al.
Digestive Diseases and Sciences|April 1, 1995
Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseasesA M Sawyerr, M S Smith, A Hall, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1991
Coagulopathy and haemorrhage in human victims of Bothrops jararaca envenoming in BrazilA S Kamiguti, J L Cardoso, R D Theakston, et al.
Thrombosis and Haemostasis|February 1, 1997
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working PartyC R Hay, W Ollier, L Pepper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2018
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive CommitteeP W Collins, R Liesner, M Makris, et al.
Thrombosis and Haemostasis|January 1, 1996
Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international surveyC R Hay, J N Lozier, C A Lee, et al.
Thrombosis and Haemostasis|May 6, 1998
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
British Journal of Clinical Pharmacology|January 1, 1988
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarinI A Choonara, R G Malia, B P Haynes, et al.
Digestive Diseases and Sciences|April 1, 1995
Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseasesA M Sawyerr, M S Smith, A Hall, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1991
Coagulopathy and haemorrhage in human victims of Bothrops jararaca envenoming in BrazilA S Kamiguti, J L Cardoso, R D Theakston, et al.
Thrombosis and Haemostasis|February 1, 1997
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working PartyC R Hay, W Ollier, L Pepper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2018
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive CommitteeP W Collins, R Liesner, M Makris, et al.
Thrombosis and Haemostasis|January 1, 1996
Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international surveyC R Hay, J N Lozier, C A Lee, et al.
Thrombosis and Haemostasis|May 6, 1998
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.
Pageof 7